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The more we learn, the more we realize that we still have to learn.
No sooner do we reach one summit than the 
next appears before us. 
It was April 1971 when I moved from Aichi
Cancer Center Research Institute (Nagoya), where I had served as section head in the Labo- 
ratory of Viral Oncology, to the Cancer Re-
search Institute(CRI)of Sapporo Medical Col- lege, and started my career as a professor at 
the newly established Department of Molecular 
Biology. Since then, twenty-six years passed 
very quickly until my retirement from the posi- 
tion in March 1997. During my tenure at CRI, 
over one hundred graduate and postdoctoral 
students and scientists from Japan and abroad spent time in our laboratory to learn and con- duct their research on viral infections and the 
molecular biology of carcinogenesis. 
The core research projects in our labora- tory were molecular biological analyses of viral carcinogenesis, cancer-related viral and celular 
genes, and viral infections. I suppose most, if not 
all,of the molecular biological studies, especially 
analyses of viral genetic information flow and the mechanism of DNA tumor virus carcino- 
genesis,originated from our early discovery with Dr. Maurice Green in St Louis University 
that viral-specific genetic information (mRNA) exists in virus-free tumors and transformed 
cells induced by adenovirus (Fujinaga and Green 1966, PNAS55:1567). Formerly, it had al- 
ready been demonstrated that highly oncogenic 
adenovirus type 12 and type 18 induce malig- 
nant tumors in new-born hamsters (Trentin, 
Yabe and Taylor 1962, Science 137:835). How- ever, there is no virus detected in these tumors. 
It was therefore a puzzling fact that the virus 
disappears from tumors and transformed cels 
induced by adenovirus and other DNA tumor 
viruses such as polyomavirus and SV40. With 
the limited molecular biology tools and tech- 
niques available at that time, it was a chalenge 
to find even where to begin in order to analyse these tumors and cells. Therefore, the molecular 
mechanism of DNA tumor virus carcinogenesis 
was completely unknown. In1966, by utilizing a 
newly improved membrane DNA-RNA hybridi- 
zation technique, we could detect for the first 
time adenovirus mRNAs as viral-specific ge- 
netic information present in virus-induced tu- mors and transformed cells. 
At CRI, we extensively investigated the 
adenovira1 genome, its transforming gene (the 
viral oncogene), and its genetic information de- tected in virus-induced tumors and transformed 
cels. We identified and determined the primary 
structure(the nucleotide sequence)of the highly oncogenic adenovirus type 12 transforming 
gene, and characterized its integration and 
mRNA transcription in tumors and transformed 
cells (Fujinaga, et aL t980 CSH Syrup. Quant. Biol44:519, Sugisaki et all980 Cell20:777). To initially conduct this research, we had to isolate 
and purify restriction endonucleases from bacte- 
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ria by ourselves in order to carry out the essen-
fiat genome analysis, because unlike now these 
enzymes were not commercialy available at 
that time. We employed several newly deve- 
loped techniques or techniques under develop- ment such as Southern and Northern blotting, 
SI mapping, and thereafter polymerase chain 
reaction(PCR), which turned out to be very use- ful and powerful. Results from the above-men- 
tioned core research projects and utilization of newly developed techniques used in these pro- 
jects opened vast possibilities for our molecular research and led to several other research pro- 
jects. These projects include characterization of human papillomavirus transforming genes in 
cervical, penile and tongue carcinomas, investi- 
gations and characterizations of viral and cellu- 
lar oncogenes and tumor suppressor genes in tumors and transformed cels, genomic analysis 
of various DNA viruses, and molecular epidemi- 
ological analysis of viral infections. Studies on 
transcription factors associated with the func-tion of adenovirus transforming genes resulted 
in the isolation and cloning of one of the human 
ets family genes, EIAF, for the first time, which 
was later demonstrated by us to be involved in 
tumor invasiveness.0ur results were published 
in more than three hundred articles(the entire 
list of publications can be found in the com- memorative booklet"A Collection of Academic 
Papers in Commemoration of Professor Kei Fuji- naga's Retirement" published in1997; as of 2010, 
the sum of the impact factors of these articles is 571 and the total number of citations is3715).
Particularly in Tumor Res., we reported many restriction endonuclease cleavage maps of sev- 
eral viral genomes and transforming genes. As 
1100k back over the events of these past26 
years, I cannot help feeling how fast time flies. 
A research team made up of scientists in differ- 
ent disciplines offers great potential.
Interdisciplinary conversations frequently bring 
out original and creative ideas.
The introduction of new technology is often the door to a new research field. 
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